A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MLS101 in Healthy Participants
Clinical trial NCT06326606 · COMPLETED
Trial details
- NCT number
- NCT06326606
- Sponsor
- MycoMedica Life Sciences PBC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-27
- Primary completion
- 2024-07-08
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.